{
    "xml": "<topic id=\"PHP3773\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/stavudine\" basename=\"stavudine\" title=\"STAVUDINE\">\n<title>STAVUDINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_401\" namespace=\"/interactions/list-of-drug-interactions/antivirals/stavudine\">Stavudine</xref>\n</p>\n<data name=\"vtmid\">108690008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_149321041\" title=\"Nucleoside reverse transcriptase inhibitors\">Nucleoside reverse transcriptase inhibitors</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34645\" title=\"NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS\" namespace=\"/drug-classes/nucleoside-reverse-transcriptase-inhibitors\">NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">d4T</p>\r\n</body>\n<topic id=\"PHP70652\" outputclass=\"indicationsAndDose\" rev=\"1.34\" parent=\"/drugs/stavudine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection in combination with other antiretroviral drugs when no suitable alternative available and when prescribed for shortest period possible</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 60 kg)</p>\n<p>30&#8239;mg every 12&#8239;hours, to be taken preferably at least 1 hour before food.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 60 kg and above)</p>\n<p>40&#8239;mg every 12&#8239;hours, to be taken preferably at least 1 hour before food.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70805\" outputclass=\"cautions\" rev=\"1.18\" parent=\"/drugs/stavudine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Excessive alcohol intake</ph>; <ph outputclass=\"caution\">higher risk of lactic acidosis than other nucleoside reverse transcriptase inhibitors (especially when used in combination with didanosine)&#8212;use only if alternative regimens are not suitable</ph>; <ph outputclass=\"caution\">history of pancreatitis</ph>; <ph outputclass=\"caution\">history of peripheral neuropathy</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70630\" outputclass=\"interactions\" rev=\"1.20\" parent=\"/drugs/stavudine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (stavudine).</p>\n<p>Caution with concomitant use of isoniazid&#8212;risk of peripheral neuropathy.</p>\n<p>Caution with concomitant use with other drugs associated with pancreatitis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70529\" outputclass=\"sideEffects\" rev=\"1.18\" parent=\"/drugs/stavudine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abnormal dreams</ph>; <ph outputclass=\"sideEffect\">cognitive dysfunction</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy (switch to another antiretroviral if peripheral neuropathy develops)</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anxiety</ph>; <ph outputclass=\"sideEffect\">gynaecomastia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70615\" outputclass=\"pregnancy\" parent=\"/drugs/stavudine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70581\" outputclass=\"renalImpairment\" parent=\"/drugs/stavudine\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Use half normal dose every 12 hours if eGFR 25&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>Use half normal dose every 24 hours if eGFR less than 25&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Risk of peripheral neuropathy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58577\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/stavudine\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of oral liquid formulations may include cherry.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70433\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.17\" parent=\"/drugs/stavudine\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>Stavudine (especially in combination with didanosine) is associated with a higher risk of lipoatrophy and should be used only if alternative regimens are not suitable; it is considered to be less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3773-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/stavudine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77097\" title=\"Capsule\" namespace=\"/drugs/stavudine/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77092\" title=\"Oral solution\" namespace=\"/drugs/stavudine/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78275\" namespace=\"/treatment-summaries/hiv-infection\" title=\"HIV infection\" count=\"1\" rel=\"backlink\">HIV infection</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_401\" namespace=\"/interactions/list-of-drug-interactions/antivirals/stavudine\" title=\"Stavudine\" count=\"1\" rel=\"link\">Stavudine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34645\" namespace=\"/drug-classes/nucleoside-reverse-transcriptase-inhibitors\" title=\"NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS\" count=\"1\" rel=\"link\">NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77097\" namespace=\"/drugs/stavudine/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77092\" namespace=\"/drugs/stavudine/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP3773",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/stavudine",
    "basename": "stavudine",
    "title": "STAVUDINE",
    "interactants": [
        {
            "id": "bnf_int_401",
            "label": "Stavudine"
        }
    ],
    "vtmid": "108690008",
    "drugClassification": [
        "Nucleoside reverse transcriptase inhibitors"
    ],
    "inheritsFromClass": [
        "NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "d4T"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "HIV infection in combination with other antiretroviral drugs when no suitable alternative available and when prescribed for shortest period possible",
                        "html": "HIV infection in combination with other antiretroviral drugs when no suitable alternative available and when prescribed for shortest period possible"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "30 mg every 12 hours, to be taken preferably at least 1 hour before food.",
                        "html": "<p>30&#8239;mg every 12&#8239;hours, to be taken preferably at least 1 hour before food.</p>",
                        "ageGroup": "(body-weight up to 60 kg)"
                    },
                    {
                        "textContent": "40 mg every 12 hours, to be taken preferably at least 1 hour before food.",
                        "html": "<p>40&#8239;mg every 12&#8239;hours, to be taken preferably at least 1 hour before food.</p>",
                        "ageGroup": "(body-weight 60 kg and above)"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Excessive alcohol intake",
                "html": "Excessive alcohol intake"
            },
            {
                "type": "cautions",
                "textContent": "higher risk of lactic acidosis than other nucleoside reverse transcriptase inhibitors (especially when used in combination with didanosine)&#8212;use only if alternative regimens are not suitable",
                "html": "higher risk of lactic acidosis than other nucleoside reverse transcriptase inhibitors (especially when used in combination with didanosine)&#8212;use only if alternative regimens are not suitable"
            },
            {
                "type": "cautions",
                "textContent": "history of pancreatitis",
                "html": "history of pancreatitis"
            },
            {
                "type": "cautions",
                "textContent": "history of peripheral neuropathy",
                "html": "history of peripheral neuropathy"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (stavudine).\n\nCaution with concomitant use of isoniazid&#8212;risk of peripheral neuropathy.\n\nCaution with concomitant use with other drugs associated with pancreatitis.",
                "html": "<p>Appendix 1 (stavudine).</p><p>Caution with concomitant use of isoniazid&#8212;risk of peripheral neuropathy.</p><p>Caution with concomitant use with other drugs associated with pancreatitis.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abnormal dreams",
                        "html": "Abnormal dreams",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cognitive dysfunction",
                        "html": "cognitive dysfunction",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "peripheral neuropathy (switch to another antiretroviral if peripheral neuropathy develops)",
                        "html": "peripheral neuropathy (switch to another antiretroviral if peripheral neuropathy develops)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Anxiety",
                        "html": "Anxiety",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "gynaecomastia",
                        "html": "gynaecomastia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Use half normal dose every 12 hours if eGFR 25&#8211;50 mL/minute/1.73 m2.\n\nUse half normal dose every 24 hours if eGFR less than 25 mL/minute/1.73 m2.",
                "html": "<p>Use half normal dose every 12 hours if eGFR 25&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>Use half normal dose every 24 hours if eGFR less than 25&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Risk of peripheral neuropathy.",
                "html": "<p>Risk of peripheral neuropathy.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of oral liquid formulations may include cherry.",
                "html": "<p>Flavours of oral liquid formulations may include cherry.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Stavudine (especially in combination with didanosine) is associated with a higher risk of lipoatrophy and should be used only if alternative regimens are not suitable; it is considered to be less suitable for prescribing.",
                "html": "<p>Stavudine (especially in combination with didanosine) is associated with a higher risk of lipoatrophy and should be used only if alternative regimens are not suitable; it is considered to be less suitable for prescribing.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77097",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77092",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78275",
                "label": "HIV infection",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_401",
                "label": "Stavudine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34645",
                "label": "NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77097",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77092",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}